Menu Search

Switzerland

SPI Large Company IndexLast 5 days
Last price17,651.41
SPI Medium Company IndexLast 5 days
Last price23,682.47
SPI Small Company IndexLast 5 days
Last price31,993.76
Swiss All-Share IndexLast 5 days
Last price805.76
SMILast 5 days
Last price12,991.25

Loading...

CHF overview

PairLatest rateToday's change1 year change
CHFGBP0.9455
GBP		-0.0003 / -0.04%0.0698 / 7.96%
Today
0.8699Apr 02 20250.9713Mar 02 2026
CHFEUR1.09
EUR		0.0029 / 0.26%0.0372 / 3.54%
Today
1.04Apr 02 20251.11Mar 09 2026
CHFUSD1.26
USD		0.007 / 0.56%0.1263 / 11.16%
Today
1.13Apr 02 20251.31Jan 27 2026
CHFJPY199.75
JPY		1.20 / 0.60%30.44 / 17.98%
Today
168.01Apr 03 2025204.00Mar 11 2026
CHFAUD1.82
AUD		0.0032 / 0.18%0.0134 / 0.74%
Today
1.78Mar 19 20262.00Apr 09 2025
CHFCAD1.75
CAD		0.0052 / 0.30%0.1275 / 7.87%
Today
1.61Apr 03 20251.79Jan 27 2026
CHFCNY8.65
CNY		0.0149 / 0.17%0.4177 / 5.08%
Today
8.20Apr 01 20259.14Jan 27 2026

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of Switzerland in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the SMI with the highest percent gain over one day.
ListingLastChangeVolume
Highlight Event and Entertainment AGHLEE:SWX5.65
CHF		+0.40
+7.62%		153.00
Wisekey International Holding AGWIHN:SWX10.36
CHF		+0.71
+7.36%		8.55k
Jungfraubahn Holding AGJFN:SWX282.00
CHF		+17.50
+6.62%		11.87k
Inficon Holding AGIFCN:SWX105.80
CHF		+6.40
+6.44%		73.71k
Komax Holding AGKOMN:SWX53.00
CHF		+2.80
+5.58%		32.90k
Cicor Technologies LtdCICN:SWX123.50
CHF		+6.50
+5.56%		18.47k
Santhera Pharmaceuticals Holding AGSANN:SWX16.38
CHF		+0.82
+5.27%		93.21k
Abb LtdABBN:SWX66.28
CHF		+3.04
+4.81%		2.72m
PolyPeptide Group AGPPGN:SWX29.70
CHF		+1.35
+4.76%		93.90k
Medartis Holding AGMED:SWX80.40
CHF		+3.60
+4.69%		12.35k
Data delayed at least 15 minutes, as of Apr 01 2026 16:35 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.